-+ 0.00%
-+ 0.00%
-+ 0.00%

Amneal Pharma's Subsidiary Pursues $1.8B Term Loan Facility, Launches $750M Senior Secured Notes Offering

Benzinga·07/21/2025 11:45:16
Listen to the news

Amneal Pharmaceuticals, Inc. ("Amneal") (NASDAQ:AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the "Issuer"), is seeking to borrow $1.800 billion aggregate principal amount of new seven-year term B loans (the "new term B loans") under a new term loan facility (the "Term Loan Facility"). The Issuer has also launched an offering of $750 million aggregate principal amount of senior secured notes due 2032 (the "notes") in a private offering.

The Issuer intends to use the net proceeds of the new term B loans and the notes to refinance its existing term B loans in full, to repay a portion of outstanding amounts borrowed under its ABL facility and to pay related fees, premiums and expenses. The offering of the notes is not conditioned on entry into the Term Loan Facility.